Pharmacokinetics and Pharmacodynamics Specialists analyze the processes that govern the movement of drugs within the body and their interactions with biological systems. Pharmacokinetics (PK) focuses on how the body absorbs, distributes, metabolizes, and eliminates drugs. It helps determine the right dosage and timing for medications to achieve therapeutic effects without causing harm. On the other hand, pharmacodynamics (PD) examines the relationship between drug concentration at the site of action and the resulting effects on the body, including efficacy and potential side effects. These specialists play a crucial role in optimizing drug therapy by ensuring that drugs are used safely and effectively across different populations. Their expertise also aids in the development of new drug delivery systems that improve drug bioavailability and therapeutic outcomes.
Pharmacologists, clinicians, and drug developers throughout the drug development process. They conduct studies to understand the drug's behavior in the body, ensuring it reaches the target site in the appropriate amount and at the right time. Pharmacokinetics and pharmacodynamics specialists are also involved in predicting drug-drug interactions and personalizing treatments based on individual genetic, metabolic, and physiological factors. Their research ensures the safe and effective use of drugs in clinical settings, contributing to the ongoing development of new therapies for a wide range of conditions.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Genetic keys and nano locks: Unlocking personalized medicine
Srividya Narayanan, Northeastern University, United States
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico